Get started
Author

Max Rothenberg

Observed names: M Rothenberg, M. Rothenberg
ORCID: 0000-0001-8816-4015
Observed ORCID: 0000-0001-8816-4015
OpenAlex ID: A5080933657
Lifestyle modification as intervention for seasonal affective disorder: A systematic review
2024 · Max Rothenberg, Barbara Nussbaumer-Streit, et al. · Journal of Psychiatric Research · 5
Prescriptions of psychopharmacologic drugs in Austria in 2019 and 2020 – Implications of the COVID-19 pandemic
2022 · Dietmar Winkler, Berthold Reichardt, et al. · European Psychiatry · 5
PDF
Factors influencing adherence to psychopharmacological medication – the doctors' perspective
2025 · Michaela Peska, Stefan Artmüller, et al. · Journal of Psychiatric Research · 2
Quirky, relatable, misleading: ADHD’s viral Identity on TikTok
2026 · Matthias Neumann, Max Rothenberg, et al. · Current Psychology · 1
PDF
Depressive symptoms in patients with schizophrenia spectrum disorders and the impact on treatment motivation and satisfaction
2026 · Max Rothenberg, Sabine Lürzer, et al. · International Journal of Psychiatry in Clinical Practice
Neurotransmitter alterations in seasonal affective disorder
2026 · B. Spurny-Dworak, G. Dörl, et al. · Scientific Reports
PDF
The effects of vortioxetine versus placebo on cognitive functioning in mild cognitive impairment
2026 · V. Matev, M. Rothenberg, et al. · Neuroscience Applied
A randomized, double-blind assessment of the effects of vortioxetine on functional connectivity in mild cognitive impairment
2025 · M Klöbl, V Matev, et al. · medRxiv
PDF
The effects of vortioxetine versus placebo on cognitive functioning in mild cognitive impairment: a placebo-controlled, randomized, double-blind study
2025 · V Matev, M Rothenberg, et al. · medRxiv
PDF
Works count: 9
Citation count: 13
H-index: 2
I10-index:
Year
Topic
Type